FDA designations and new study publications Recent developments include Phase 2 DMD Study Breakthrough Results ...

U.S. 503B Compounding Pharmacies Market Trend and Size U.S 503B compounding pharmacies market is estimated to be valued at US$ 985.6 mn in ...

Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined net revenues of $10.4 million during the ...